Authentication of M14 melanoma cell line proves misidentification of MDA-MB-435 breast cancer cell line
- PMID: 28940260
- PMCID: PMC5762610
- DOI: 10.1002/ijc.31067
Authentication of M14 melanoma cell line proves misidentification of MDA-MB-435 breast cancer cell line
Abstract
A variety of analytical approaches have indicated that melanoma cell line UCLA-SO-M14 (M14) and breast carcinoma cell line MDA-MB-435 originate from a common donor. This indicates that at some point in the past, one of these cell lines became misidentified, meaning that it ceased to correspond to the reported donor and instead became falsely identified (through cross-contamination or other means) as a cell line from a different donor. Initial studies concluded that MDA-MB-435 was the misidentified cell line and M14 was the authentic cell line, although contradictory evidence has been published, resulting in further confusion. To address this question, we obtained early samples of the melanoma cell line (M14), a lymphoblastoid cell line from the same donor (ML14), and donor serum preserved at the originator's institution. M14 samples were cryopreserved in December 1975, before MDA-MB-435 cells were established in culture. Through a series of molecular characterizations, including short tandem repeat (STR) profiling and cytogenetic analysis, we demonstrated that later samples of M14 and MDA-MB-435 correspond to samples of M14 frozen in 1975, to the lymphoblastoid cell line ML14, and to the melanoma donor's STR profile, sex and blood type. This work demonstrates conclusively that M14 is the authentic cell line and MDA-MB-435 is misidentified. With clear provenance information and authentication testing of early samples, it is possible to resolve debates regarding the origins of problematic cell lines that are widely used in cancer research.
Keywords: STR profiling; authentication; cross-contamination; human cell lines; misidentification.
© 2017 The Authors International Journal of Cancer published by John Wiley & Sons Ltd on behalf of UICC.
Figures
Similar articles
-
MDA-MB-435 and M14 cell lines: identical but not M14 melanoma?Cancer Res. 2009 Jul 1;69(13):5292-3. doi: 10.1158/0008-5472.CAN-09-1528. Epub 2009 Jun 23. Cancer Res. 2009. PMID: 19549886
-
MDA-MB-435 cells are derived from M14 melanoma cells--a loss for breast cancer, but a boon for melanoma research.Breast Cancer Res Treat. 2007 Jul;104(1):13-9. doi: 10.1007/s10549-006-9392-8. Epub 2006 Sep 27. Breast Cancer Res Treat. 2007. PMID: 17004106
-
Comment Re: MDA-MB-435 and M14 cell lines: identical but not M14 Melanoma?Cancer Res. 2009 Oct 1;69(19):7893. doi: 10.1158/0008-5472.CAN-09-2396. Epub 2009 Sep 1. Cancer Res. 2009. PMID: 19723654 No abstract available.
-
MDA-MB-435: the questionable use of a melanoma cell line as a model for human breast cancer is ongoing.Cancer Biol Ther. 2007 Sep;6(9):1355-7. doi: 10.4161/cbt.6.9.4624. Epub 2007 Jun 23. Cancer Biol Ther. 2007. PMID: 17786032 Review.
-
Authentication of Human and Mouse Cell Lines by Short Tandem Repeat (STR) DNA Genotype Analysis.2023 Jan 17. In: Markossian S, Grossman A, Brimacombe K, Arkin M, Auld D, Austin C, Baell J, Chung TDY, Coussens NP, Dahlin JL, Devanarayan V, Foley TL, Glicksman M, Gorshkov K, Haas JV, Hall MD, Hoare S, Inglese J, Iversen PW, Kales SC, Lal-Nag M, Li Z, McGee J, McManus O, Riss T, Saradjian P, Sittampalam GS, Tarselli M, Trask OJ Jr, Wang Y, Weidner JR, Wildey MJ, Wilson K, Xia M, Xu X, editors. Assay Guidance Manual [Internet]. Bethesda (MD): Eli Lilly & Company and the National Center for Advancing Translational Sciences; 2004–. 2023 Jan 17. In: Markossian S, Grossman A, Brimacombe K, Arkin M, Auld D, Austin C, Baell J, Chung TDY, Coussens NP, Dahlin JL, Devanarayan V, Foley TL, Glicksman M, Gorshkov K, Haas JV, Hall MD, Hoare S, Inglese J, Iversen PW, Kales SC, Lal-Nag M, Li Z, McGee J, McManus O, Riss T, Saradjian P, Sittampalam GS, Tarselli M, Trask OJ Jr, Wang Y, Weidner JR, Wildey MJ, Wilson K, Xia M, Xu X, editors. Assay Guidance Manual [Internet]. Bethesda (MD): Eli Lilly & Company and the National Center for Advancing Translational Sciences; 2004–. PMID: 23805434 Free Books & Documents. Review.
Cited by
-
Imaging modification of colon carcinoma cells exposed to lipid based nanovectors for drug delivery: a scanning electron microscopy investigation.RSC Adv. 2019 Jul 15;9(38):21810-21825. doi: 10.1039/c9ra02381j. eCollection 2019 Jul 11. RSC Adv. 2019. PMID: 35518842 Free PMC article.
-
Chemical alternative for cell identification and cross-contamination detection.3 Biotech. 2022 Mar;12(3):78. doi: 10.1007/s13205-022-03144-z. Epub 2022 Feb 25. 3 Biotech. 2022. PMID: 35251881 Free PMC article.
-
Jadomycins: A potential chemotherapy for multi-drug resistant metastatic breast cancer.Pharmacol Res Perspect. 2021 Dec;9(6):e00886. doi: 10.1002/prp2.886. Pharmacol Res Perspect. 2021. PMID: 34708587 Free PMC article. Review.
-
Multicenter, double-blind, placebo-controlled trial of seviprotimut-L polyvalent melanoma vaccine in patients with post-resection melanoma at high risk of recurrence.J Immunother Cancer. 2021 Oct;9(10):e003272. doi: 10.1136/jitc-2021-003272. J Immunother Cancer. 2021. PMID: 34599031 Free PMC article.
-
Peptide-Modified Biopolymers for Biomedical Applications.ACS Appl Bio Mater. 2021 Jan 18;4(1):229-251. doi: 10.1021/acsabm.0c01145. Epub 2020 Dec 24. ACS Appl Bio Mater. 2021. PMID: 34250454 Free PMC article. Review.
References
-
- Ross DT, Scherf U, Eisen MB, et al. Systematic variation in gene expression patterns in human cancer cell lines. Nat Genet 2000;24:227–35. - PubMed
-
- Rae JM, Ramus SJ, Waltham M, et al. Common origins of MDA‐MB‐435 cells from various sources with those shown to have melanoma properties. Clin Exp Metastasis 2004;21:543–52. - PubMed
-
- Rae JM, Creighton CJ, Meck JM, et al. MDA‐MB‐435 cells are derived from M14 melanoma cells–a loss for breast cancer, but a boon for melanoma research. Breast Cancer Res Treat 2007;104:13–9. - PubMed
Publication types
MeSH terms
Substances
Grant support
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
